Moderna, Merck vaccine cuts recurrence and spread of melanoma, raising new treatment hope

By Michael Erman and Julie Steenhuysen Aug 19 (Reuters) - Moderna and Merck said on Wednesday that a personalized mRNA cancer ...

A vaccine for melanoma recurrence? Merck, Moderna say trial promising

Merck and Moderna say the experimental treatment extended the time before skin cancer returned in patients at high risk.

mRNA Cancer Vaccine Cuts Melanoma Recurrence in Landmark Phase 3 Trial

RNA cancer vaccine intismeran cut melanoma recurrence in a landmark Phase 3 trial, marking the first randomized proof a ...
Healthline

Moderna, Merck Melanoma Vaccine May Help Reduce Recurrence, Spread

New phase 3 results for Moderna and Merck’s personalized mRNA melanoma vaccine support earlier findings showing a 49% lower ...

Moderna and Merck say melanoma vaccine succeeded in large trial

Moderna’s mRNA vaccine combined with Merck’s immunotherapy Keytruda succeeded in a late-stage trial for skin cancer, the ...
Emirates 24/7

Moderna shares soar after cancer vaccine cuts melanoma recurrence

Moderna shares surge as personalised mRNA cancer vaccine with Merck's Keytruda cuts melanoma recurrence and spread in ...
Cancer Therapy Advisor

Tissue-Free ctDNA Detection “Strongly Prognostic” of Recurrence in Early TNBC

In this study, researchers evaluated the validity and prognostic value of tissue-free ctDNA analysis among 159 patients with early TNBC who were part of the phase 2 cTRAK trial.

Moderna vaccine cuts recurrence and spread of high-risk melanoma, raising new treatment hope

By Michael Erman and Julie Steenhuysen Aug 19 (Reuters) - Moderna said on Wednesday that a personalized mRNA cancer vaccine ...